Active Ingredient:

  • Lastlerge is the FIRST & ONLY Mizolastine in Egypt introduced in market, H1 2nd generation Antihistamine , long acting & non-sedating approved by EMA in treating Allergic Rhinoconjunctivitis and Urticaria in 1996


  • Lastlerge 10mg used in adult including elderly and children 12 years of age and over (once daily dose) .


  • Lastlerge available in a pack of 14 tablets.